Effectiveness of Antibiotic Prophylaxis for Totally Implantable Venous Access Device
NCT ID: NCT00867295
Last Updated: 2010-06-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
150 participants
INTERVENTIONAL
2008-09-30
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Microorganisms on Reusable Tourniquets
NCT06566495
Rate of Catheter Colonization and Risk of Bloodstream Infection During Use of Two Different Central Venous Catheters (CVC)
NCT00555282
The Performance / Safety of the Celsite® Venous Access Ports
NCT05572112
Effect Of Open And Closed System Peripheral Catheters Used In Pediatric Services
NCT06312215
Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors
NCT01098643
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
placebo
no antibiotic is used
placebo
placebo
drug
cefazolin Sodium 1g i.v. before the operation
cefazolin Sodium
cefazolin Sodium 1g i.v. before operation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cefazolin Sodium
cefazolin Sodium 1g i.v. before operation
placebo
placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have solid tumor
* White cells \>4000
* Platelets \>100.000
* Prothrombin time in normal range
Exclusion Criteria
* Diabetes mellitus
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Istanbul University Institute of Oncology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hasan Karanlik, MD
Role: PRINCIPAL_INVESTIGATOR
Istanbul University Institute of Oncology Department of Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul University Institute of Oncology
Istanbul, Capa, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Karanlik H, Kurul S, Saip P, Unal ES, Sen F, Disci R, Topuz E. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single-center prospective randomized trial. Am J Surg. 2011 Jul;202(1):10-5. doi: 10.1016/j.amjsurg.2010.05.005. Epub 2011 May 23.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009/22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.